Topical Application of Latanoprost in Diabetic Retinopathy

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Randomized double-blinded two-year intervention study with topical application of latanoprost or placebo eye drops in patients with diabetic retinopathy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Aarhus
• Collaborator: Aarhus University Hospital
• Treatments: Latanoprost

Criteria

Inclusion Criteria:

• Age 20-36 years old

• Diabetes mellitus with retinopathy

Exclusion Criteria:

• Pregnancy

• Previous ocular disease other than diabetic retinopathy

• General disease with possible influence on the eye